Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program

I. Abouyahya, C. Alhan, T.M. Westers, P.A. te Boekhorst, MC Kappers-Klunne, J.L. Coenen, F.H. Heyning, G.A. Huls, JT de Wolf, A.L. Imholz, H.R. Koene, G. Veth, E.J.F.M. de Kruijf, P. Muus, E.V. Planken, C.M. Segeren, W.L. Vasmel, A.M. van der Velden, G.A. Velders, J. KoedamG.J. Ossenkoppele, A.A. van de Loosdrecht

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)874-877
JournalLeukemia and Lymphoma
Issue number4
Publication statusPublished - 2013

Cite this